Northern Trust’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.53M Buy
310,724
+5,603
+2% +$60.7K ﹤0.01% 2645
2025
Q4
$3.92M Sell
305,121
-22,158
-7% -$274K ﹤0.01% 2613
2025
Q3
$3.66M Buy
327,279
+494
+0.2% +$4.77K ﹤0.01% 2683
2025
Q2
$3.24M Sell
326,785
-15,145
-4% -$148K ﹤0.01% 2725
2025
Q1
$3.21M Sell
341,930
-9,435
-3% -$99.2K ﹤0.01% 2659
2024
Q4
$3.22M Buy
351,365
+8,260
+2% +$60.7K ﹤0.01% 2768
2024
Q3
$2.67M Buy
343,105
+514
+0.2% +$3.71K ﹤0.01% 2816
2024
Q2
$2.07M Buy
342,591
+2,318
+0.7% +$14.3K ﹤0.01% 2879
2024
Q1
$2M Sell
340,273
-7,584
-2% -$45.1K ﹤0.01% 2963
2023
Q4
$2.73M Sell
347,857
-24,465
-7% -$170K ﹤0.01% 2823
2023
Q3
$2.72M Sell
372,322
-39,514
-10% -$329K ﹤0.01% 2769
2023
Q2
$4.3M Sell
411,836
-297,834
-42% -$2.87M ﹤0.01% 2583
2023
Q1
$7.34M Sell
709,670
-9,801
-1% -$125K ﹤0.01% 2225
2022
Q4
$9.91M Sell
719,471
-121
-0% -$1.68K ﹤0.01% 2011
2022
Q3
$14.7M Sell
719,592
-9,899
-1% -$217K ﹤0.01% 1709
2022
Q2
$14.1M Sell
729,491
-8,289
-1% -$170K ﹤0.01% 1772
2022
Q1
$15.9M Sell
737,780
-27,611
-4% -$626K ﹤0.01% 1838
2021
Q4
$21.1M Sell
765,391
-7,316
-0.9% -$202K ﹤0.01% 1730
2021
Q3
$20M Sell
772,707
-25,645
-3% -$686K ﹤0.01% 1811
2021
Q2
$21.7M Buy
798,352
+12,651
+2% +$309K ﹤0.01% 1833
2021
Q1
$18.4M Sell
785,701
-375,809
-32% -$7.6M ﹤0.01% 1882
2020
Q4
$17.8M Sell
1,161,510
-22,777
-2% -$289K ﹤0.01% 1868
2020
Q3
$14.3M Sell
1,184,287
-17,260
-1% -$164K ﹤0.01% 1873
2020
Q2
$12.2M Buy
1,201,547
+542
+0% +$5.59K ﹤0.01% 1981
2020
Q1
$12.5M Buy
1,201,005
+7,232
+0.6% +$90.8K ﹤0.01% 1732
2019
Q4
$19.1M Sell
1,193,773
-5,123
-0.4% -$78.2K ﹤0.01% 1754
2019
Q3
$22.1M Buy
1,198,896
+19,231
+2% +$376K 0.01% 1612
2019
Q2
$23.2M Buy
1,179,665
+11,387
+1% +$232K 0.01% 1572
2019
Q1
$26.7M Sell
1,168,278
-4,132
-0.4% -$89.7K 0.01% 1449
2018
Q4
$23.6M Sell
1,172,410
-2,015
-0.2% -$41.7K 0.01% 1435
2018
Q3
$25.5M Sell
1,174,425
-35,222
-3% -$782K 0.01% 1590
2018
Q2
$26.9M Buy
1,209,647
+9,119
+0.8% +$186K 0.01% 1542
2018
Q1
$20.7M Buy
1,200,528
+2,540
+0.2% +$42.4K 0.01% 1659
2017
Q4
$19.9M Sell
1,197,988
-10,834
-0.9% -$185K 0.01% 1704
2017
Q3
$20.7M Buy
1,208,822
+5,881
+0.5% +$98.8K 0.01% 1689
2017
Q2
$19.5M Buy
1,202,941
+155,951
+15% +$2.47M 0.01% 1694
2017
Q1
$18.2M Buy
1,046,990
+23,939
+2% +$400K 0.01% 1697
2016
Q4
$17.3M Buy
1,023,051
+25,674
+3% +$428K 0.01% 1707
2016
Q3
$17.5M Buy
997,377
+21,422
+2% +$347K 0.01% 1695
2016
Q2
$14M Buy
975,955
+31,827
+3% +$398K ﹤0.01% 1790
2016
Q1
$11.6M Buy
944,128
+25,274
+3% +$279K ﹤0.01% 1866
2015
Q4
$11.2M Sell
918,854
-156,048
-15% -$1.92M ﹤0.01% 1941
2015
Q3
$14.2M Buy
1,074,902
+147,652
+16% +$2.23M ﹤0.01% 1740
2015
Q2
$15.2M Buy
927,250
+56,656
+7% +$941K ﹤0.01% 1782
2015
Q1
$15.5M Buy
870,594
+156,120
+22% +$2.9M ﹤0.01% 1772
2014
Q4
$13.6M Sell
714,474
-822
-0.1% -$13.9K ﹤0.01% 1833
2014
Q3
$9.81M Buy
715,296
+13,107
+2% +$187K ﹤0.01% 2052
2014
Q2
$11.5M Sell
702,189
-7,659
-1% -$111K ﹤0.01% 1936
2014
Q1
$11.2M Sell
709,848
-25,099
-3% -$409K ﹤0.01% 2030
2013
Q4
$12.6M Buy
734,947
+22,845
+3% +$352K ﹤0.01% 1914
2013
Q3
$9.4M Sell
712,102
-21,726
-3% -$256K ﹤0.01% 2074
2013
Q2
$8.28M Buy
+733,828
New +$7.81M ﹤0.01% 2055

Other funds holding ANGO

Northern Trust's ANGO Position: Q1 2026 in Review

Northern Trust increased its AngioDynamics (ANGO) stake by 1.8% in Q1 2026, buying an estimated $60.7K and bringing the position to 310,724 shares worth $3.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Northern Trust first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.9M in Q2 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Northern Trust held 310,724 shares of AngioDynamics worth $3.53M as of Q1 2026.
  • Northern Trust bought 5,603 AngioDynamics shares in Q1 2026, an estimated $60.7K.
  • AngioDynamics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2645 holding.
  • Northern Trust first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's AngioDynamics position peaked at $26.9M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.